{ "schemaVersion": "1.0.0", "project": "Type1Cure.com", "generatedAt": "2026-06-13T09:17:02.630Z", "sourceFeedGeneratedAt": "2026-06-13T09:17:02.630Z", "postCount": 5, "posts": [ { "id": "blog:2026-06-13:daily-type-1-diabetes-briefing", "slug": "2026-06-13-daily-type-1-diabetes-briefing", "title": "June 13, 2026 Type 1 diabetes briefing: trials, device safety, and research signals", "dek": "A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.", "category": "Daily Briefing", "topic": "daily-brief", "author": "Type1Cure Editorial Desk", "publishedAt": "2026-06-13T08:00:00.000Z", "updatedAt": "2026-06-13T09:17:02.630Z", "readingTimeMinutes": 3, "image": { "src": "/images/hero-t1d-command-center.png", "alt": "A Type 1 diabetes intelligence desk with research, device, and care-planning materials.", "credit": "Type1Cure original generated editorial image", "license": "Project-owned generated asset" }, "tags": [ "daily briefing", "type 1 diabetes", "trials", "device safety", "research" ], "sourceItemIds": [ "clinicaltrials:NCT07039942", "clinicaltrials:NCT06878872", "openfda-device-recall:219288", "openfda-device-recall:219289", "openfda-device-recall:219290", "clinicaltrials:NCT04963777", "openfda-device-recall:219498", "clinicaltrials:NCT07548996", "openfda-device-recall:219130", "openfda-device-recall:217834" ], "sources": [ { "title": "French Prospective Multicentric Study in Real World", "url": "https://clinicaltrials.gov/study/NCT07039942", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-29" }, { "title": "Type 1 Diabetes Adolescents for Healthier Lifestyles Study", "url": "https://clinicaltrials.gov/study/NCT06878872", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-13" }, { "title": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: Versions 2.9.0 through 2.11.2 Produc...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219288", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: Versions 2.9.0 through 2.11.2 Pr...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219289", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "Dexcom, Inc.: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.5.0 and 1.6.0 Product...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219290", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "Prebiotics in Patients With Type 1 Diabetes", "url": "https://clinicaltrials.gov/study/NCT04963777", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-01" }, { "title": "North American Rescue LLC.: AIDBAGs are first aid kits of convenience composed of individually labeled devices designed as specialty first aid kits designed for the appropriate level provider to evaluate and...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219498", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-29" }, { "title": "Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes", "url": "https://clinicaltrials.gov/study/NCT07548996", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-04-23" }, { "title": "FDA device recall: Omnipod 5 Pods. Model/Catalog number: PT-001662 ASM 5PK Pod STRL OPS G6G7", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219130", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-10" }, { "title": "Medtronic MiniMed, Inc.: MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782)", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=217834", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-02" } ], "sections": [ { "heading": "The short version", "paragraphs": [ "The June 13, 2026 feed is strongest in three lanes: device safety, recruiting studies, and recent research records. Type1Cure treats safety and trial records as higher-priority signals because they can affect what a family may need to check, ask, or watch next.", "This is not a medical recommendation. It is a source map and plain-English triage layer designed to help families decide what deserves a closer look with their care team." ] }, { "heading": "Signals in the feed", "bullets": [ { "text": "French Prospective Multicentric Study in Real World — RECRUITING. Interventions: Omnipod 5. Locations: Angers, France | Besançon, France | Bobigny, France. The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life,...", "sourceUrl": "https://clinicaltrials.gov/study/NCT07039942" }, { "text": "Type 1 Diabetes Adolescents for Healthier Lifestyles Study — RECRUITING, NA. Interventions: T1DAL Program. Locations: Providence, Rhode Island, United States. Before the 1990s, obesity was rare among young people with type 1 diabetes (T1D), but now it is more common. Recent studi...", "sourceUrl": "https://clinicaltrials.gov/study/NCT06878872" }, { "text": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: Versions 2.9.0 through 2.11.2 Produc... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219288" }, { "text": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: Versions 2.9.0 through 2.11.2 Pr... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219289" }, { "text": "Dexcom, Inc.: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.5.0 and 1.6.0 Product... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219290" }, { "text": "Prebiotics in Patients With Type 1 Diabetes — RECRUITING, NA. Interventions: Prebiotic, Placebo. Locations: Calgary, Alberta, Canada | Edmonton, Alberta, Canada | Saskatoon, Saskatchewan, Canada. Evidence suggests that prebiotic fibre can correct dysbiosis, reduce...", "sourceUrl": "https://clinicaltrials.gov/study/NCT04963777" }, { "text": "North American Rescue LLC.: AIDBAGs are first aid kits of convenience composed of individually labeled devices designed as specialty first aid kits designed for the appropriate level provider to evaluate and... — Kits contain the McKesson TRUE Metrix PRO Professional Monitoring Blood Glucose System that has been recalled for an issue with the software design of the E-5 Error Code where the meter displays an E-5 error code for a...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219498" } ] }, { "heading": "How to use this briefing", "paragraphs": [ "Start with the evidence label. Official registry and regulator records are not the same thing as advice, but they are stronger source material than a repost, rumor, or promotional headline.", "For trials, check eligibility, location, burden, intervention, and contact details at the original registry. For device safety, check exact product names, models, lot numbers, software versions, and manufacturer instructions." ] } ], "medicalDisclaimer": "This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.", "seo": { "title": "June 13, 2026 Type 1 diabetes briefing: trials, device safety, and research signals", "description": "A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance." } }, { "id": "blog:2026-06-13:device-safety-watch", "slug": "2026-06-13-device-safety-watch", "title": "Type 1 diabetes device safety watch: latest FDA recall signals families should review", "dek": "A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.", "category": "Device Safety", "topic": "device-safety", "author": "Type1Cure Editorial Desk", "publishedAt": "2026-06-13T08:00:00.000Z", "updatedAt": "2026-06-13T09:17:02.630Z", "readingTimeMinutes": 3, "image": { "src": "/images/open-source/cgm-washington-dc.jpg", "alt": "A continuous glucose monitor worn on the arm.", "credit": "Ted Eytan / Wikimedia Commons", "license": "CC BY-SA 2.0", "sourceUrl": "https://commons.wikimedia.org/wiki/File:2018.11.03_Continuous_Glucose_Monitor_14_day,_Washington,_DC_USA_3458-2_(43893890200).jpg" }, "tags": [ "device safety", "FDA recalls", "CGM", "insulin pump", "Type 1 diabetes" ], "sourceItemIds": [ "openfda-device-recall:219288", "openfda-device-recall:219289", "openfda-device-recall:219290", "openfda-device-recall:219498", "openfda-device-recall:219130", "openfda-device-recall:217834", "openfda-device-recall:218909", "openfda-device-recall:218910", "openfda-device-recall:219223", "openfda-device-recall:219224" ], "sources": [ { "title": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: Versions 2.9.0 through 2.11.2 Produc...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219288", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: Versions 2.9.0 through 2.11.2 Pr...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219289", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "Dexcom, Inc.: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.5.0 and 1.6.0 Product...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219290", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "North American Rescue LLC.: AIDBAGs are first aid kits of convenience composed of individually labeled devices designed as specialty first aid kits designed for the appropriate level provider to evaluate and...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219498", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-29" }, { "title": "FDA device recall: Omnipod 5 Pods. Model/Catalog number: PT-001662 ASM 5PK Pod STRL OPS G6G7", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219130", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-10" }, { "title": "Medtronic MiniMed, Inc.: MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782)", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=217834", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-02" }, { "title": "Medtronic MiniMed, Inc.: MiniMed 630G Insulin Pump (MMT-1714, MMT-1715, MMT-1754, MMT-1755)", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=218909", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-02" }, { "title": "Medtronic MiniMed, Inc.: MiniMed 780G Insulin Pump (MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896)", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=218910", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-02" }, { "title": "Medtronic MiniMed, Inc.: MiniMed 770G Insulin Pump (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219223", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-02" }, { "title": "Medtronic MiniMed, Inc.: MiniMed 640G Insulin Pump (MMT-1711, MMT-1712, MMT-1751, MMT-1752)", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219224", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-04-02" } ], "sections": [ { "heading": "Why this lane comes first", "paragraphs": [ "For a Type 1 diabetes family, device and supply failures can become urgent faster than ordinary research news. A recall record may point to a software issue, model-specific device problem, replacement path, or safety instruction that deserves immediate review.", "The right workflow is product-specific: compare the exact device, app, model, lot, and instructions in the official source before assuming a recall applies." ] }, { "heading": "Current safety records in the feed", "bullets": [ { "text": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: Versions 2.9.0 through 2.11.2 Produc... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219288" }, { "text": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: Versions 2.9.0 through 2.11.2 Pr... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219289" }, { "text": "Dexcom, Inc.: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.5.0 and 1.6.0 Product... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219290" }, { "text": "North American Rescue LLC.: AIDBAGs are first aid kits of convenience composed of individually labeled devices designed as specialty first aid kits designed for the appropriate level provider to evaluate and... — Kits contain the McKesson TRUE Metrix PRO Professional Monitoring Blood Glucose System that has been recalled for an issue with the software design of the E-5 Error Code where the meter displays an E-5 error code for a...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219498" }, { "text": "FDA device recall: Omnipod 5 Pods. Model/Catalog number: PT-001662 ASM 5PK Pod STRL OPS G6G7 — Due to a manufacturing defect, certain Omnipod 5 Pods from 49 lots have an internal soft cannula tear that results in insulin leaking into the Pod instead of being delivered to the user regardless of basal or bolus deli...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219130" }, { "text": "Medtronic MiniMed, Inc.: MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782) — All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the inf...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=217834" }, { "text": "Medtronic MiniMed, Inc.: MiniMed 630G Insulin Pump (MMT-1714, MMT-1715, MMT-1754, MMT-1755) — All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the inf...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=218909" }, { "text": "Medtronic MiniMed, Inc.: MiniMed 780G Insulin Pump (MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896) — All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the inf...", "sourceUrl": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=218910" } ] }, { "heading": "Family checklist", "bullets": [ { "text": "Check whether the product name, model, app version, lot number, or serial number matches anything in your home." }, { "text": "Use the manufacturer or FDA instructions in the linked record; do not rely on reposted summaries." }, { "text": "Bring uncertain device questions to the diabetes care team, especially when insulin delivery or glucose readings may be affected." } ] } ], "medicalDisclaimer": "This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.", "seo": { "title": "Type 1 diabetes device safety watch: latest FDA recall signals families should review", "description": "A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records." } }, { "id": "blog:2026-06-13:recruiting-type-1-diabetes-trials-watch", "slug": "2026-06-13-recruiting-type-1-diabetes-trials-watch", "title": "Recruiting Type 1 diabetes trials watch: what changed in the current registry feed", "dek": "A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.", "category": "Clinical Trials", "topic": "trials", "author": "Type1Cure Editorial Desk", "publishedAt": "2026-06-13T08:00:00.000Z", "updatedAt": "2026-06-13T09:17:02.630Z", "readingTimeMinutes": 3, "image": { "src": "/images/open-source/diabetes-education-community.jpg", "alt": "A diabetes education and community support setting.", "credit": "Carolyn Rafieymehr / Wikimedia Commons", "license": "Public domain", "sourceUrl": "https://commons.wikimedia.org/wiki/File:Chabot.JPG" }, "tags": [ "clinical trials", "ClinicalTrials.gov", "T1D", "trial matching" ], "sourceItemIds": [ "clinicaltrials:NCT07039942", "clinicaltrials:NCT06878872", "clinicaltrials:NCT04963777", "clinicaltrials:NCT07548996", "clinicaltrials:NCT06329375", "clinicaltrials:NCT07455994", "clinicaltrials:NCT05626712", "clinicaltrials:NCT05734313", "clinicaltrials:NCT07185555", "clinicaltrials:NCT06729242" ], "sources": [ { "title": "French Prospective Multicentric Study in Real World", "url": "https://clinicaltrials.gov/study/NCT07039942", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-29" }, { "title": "Type 1 Diabetes Adolescents for Healthier Lifestyles Study", "url": "https://clinicaltrials.gov/study/NCT06878872", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-13" }, { "title": "Prebiotics in Patients With Type 1 Diabetes", "url": "https://clinicaltrials.gov/study/NCT04963777", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-01" }, { "title": "Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes", "url": "https://clinicaltrials.gov/study/NCT07548996", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-04-23" }, { "title": "Food Insecurity Reduction & Strategy Team", "url": "https://clinicaltrials.gov/study/NCT06329375", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-03-13" }, { "title": "Dysautonomia in Children With Type 1 Diabetes", "url": "https://clinicaltrials.gov/study/NCT07455994", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-03-06" }, { "title": "Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes", "url": "https://clinicaltrials.gov/study/NCT05626712", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-02-19" }, { "title": "Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression", "url": "https://clinicaltrials.gov/study/NCT05734313", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2025-10-30" }, { "title": "Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded Hybrid Closed Loop System", "url": "https://clinicaltrials.gov/study/NCT07185555", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2025-09-29" }, { "title": "Influence of Menstrual Cycle Phases on the Glycemic Control of Aerobic or HIIT Exercise in Adult Women With Type 1 Diabetes", "url": "https://clinicaltrials.gov/study/NCT06729242", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2025-07-08" } ], "sections": [ { "heading": "What this is and is not", "paragraphs": [ "This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.", "A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?" ] }, { "heading": "Recruiting records to inspect", "bullets": [ { "text": "French Prospective Multicentric Study in Real World — RECRUITING. Interventions: Omnipod 5. Locations: Angers, France | Besançon, France | Bobigny, France. The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life,...", "sourceUrl": "https://clinicaltrials.gov/study/NCT07039942" }, { "text": "Type 1 Diabetes Adolescents for Healthier Lifestyles Study — RECRUITING, NA. Interventions: T1DAL Program. Locations: Providence, Rhode Island, United States. Before the 1990s, obesity was rare among young people with type 1 diabetes (T1D), but now it is more common. Recent studi...", "sourceUrl": "https://clinicaltrials.gov/study/NCT06878872" }, { "text": "Prebiotics in Patients With Type 1 Diabetes — RECRUITING, NA. Interventions: Prebiotic, Placebo. Locations: Calgary, Alberta, Canada | Edmonton, Alberta, Canada | Saskatoon, Saskatchewan, Canada. Evidence suggests that prebiotic fibre can correct dysbiosis, reduce...", "sourceUrl": "https://clinicaltrials.gov/study/NCT04963777" }, { "text": "Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes — RECRUITING, PHASE2, PHASE3. Interventions: Dimethyl Fumarate Enteric-coated Capsules, Insulin. Locations: Nanjing, Jiangsu, China. This is a non-randomized, parallel-controlled, single-center, open-label clinical trial...", "sourceUrl": "https://clinicaltrials.gov/study/NCT07548996" }, { "text": "Food Insecurity Reduction & Strategy Team — RECRUITING, NA. Interventions: Nutrition program. Locations: Palo Alto, California, United States. This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on hea...", "sourceUrl": "https://clinicaltrials.gov/study/NCT06329375" }, { "text": "Dysautonomia in Children With Type 1 Diabetes — RECRUITING, NA. Interventions: Neurocoach® and Sudoscan®. Locations: Saint-Etienne, France. Some physiological factors, such as physical activity, or pathological factors, such as sepsis or diabetes, are known to modula...", "sourceUrl": "https://clinicaltrials.gov/study/NCT07455994" }, { "text": "Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes — RECRUITING, PHASE1, PHASE2. Interventions: CELZ-201 Administration, Control Group. Locations: Miami, Florida, United States. The brief purpose of this research study is to learn about the safety and efficacy of intra-ar...", "sourceUrl": "https://clinicaltrials.gov/study/NCT05626712" }, { "text": "Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression — RECRUITING, NA. Interventions: Unified protocol for cognitive behavioral therapy (UP-CBT), Continuous Glucose Monitoring (CGM). Locations: Boston, Massachusetts, United States | The Bronx, New York, United States. This...", "sourceUrl": "https://clinicaltrials.gov/study/NCT05734313" } ] }, { "heading": "Questions before contacting a study", "bullets": [ { "text": "Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?" }, { "text": "What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?" }, { "text": "Can the family discuss the official record with their endocrinology team before sharing additional personal health details?" } ] } ], "medicalDisclaimer": "This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.", "seo": { "title": "Recruiting Type 1 diabetes trials watch: what changed in the current registry feed", "description": "A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families." } }, { "id": "blog:2026-06-13:research-watch", "slug": "2026-06-13-research-watch", "title": "Type 1 diabetes research watch: recent papers and DOI records worth sorting", "dek": "A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.", "category": "Research Watch", "topic": "research", "author": "Type1Cure Editorial Desk", "publishedAt": "2026-06-13T08:00:00.000Z", "updatedAt": "2026-06-13T09:17:02.630Z", "readingTimeMinutes": 3, "image": { "src": "/images/open-source/pancreas-insulin-beta-cells.png", "alt": "Educational diagram of pancreatic insulin-producing beta cells.", "credit": "National Diabetes Information Clearinghouse / Wikimedia Commons", "license": "Public domain", "sourceUrl": "https://commons.wikimedia.org/wiki/File:Pancreas_insulin_beta_cells.png" }, "tags": [ "research", "PubMed", "Crossref", "beta cells", "immunotherapy" ], "sourceItemIds": [ "crossref:10.32598/jccnc.7.1.356.1", "crossref:10.22179/revmacn.20.482", "crossref:10.5455/jmhe.2015.08.015", "crossref:10.7900/jot.2011may12.1971", "crossref:10.23975/bjvetr.2031.175855", "crossref:10.3917/spub.pr2.0051", "crossref:10.21608/ejmm.2026.490039.2433", "crossref:10.22158/eltls.v8n3p21", "pubmed:42070103", "pubmed:42017902", "pubmed:41774510", "pubmed:41823267" ], "sources": [ { "title": "Comparing of the Effects of Acceptance and Commitment Therapy and Emotion Regulation Training on Diabetes Empowerment", "url": "https://doi.org/10.32598/jccnc.7.1.356.1", "sourceName": "Crossref", "evidenceLabel": "DOI-indexed publication", "publishedAt": "2121-02-01" }, { "title": "Geographical distribution of Corydoras micracanthus Regan 1912 (Siluriformes: Callichthyidae), with comments on its behavior and type locality.", "url": "https://doi.org/10.22179/revmacn.20.482", "sourceName": "Crossref", "evidenceLabel": "DOI-indexed publication", "publishedAt": "2108-01-01" }, { "title": "Re-Evaluating the Efficacy of the Aqueous Leaf Extract of Bridelia ferrugenia and its Potential Combination with Metformin in the Management of Diabetes Mellitus", "url": "https://doi.org/10.5455/jmhe.2015.08.015", "sourceName": "Crossref", "evidenceLabel": "DOI-indexed publication", "publishedAt": "2105-01-01" }, { "title": "A Birkhoff type transitivity theorem for non-separable completely metrizable spaces with applications to linear dynamics", "url": "https://doi.org/10.7900/jot.2011may12.1971", "sourceName": "Crossref", "evidenceLabel": "DOI-indexed publication", "publishedAt": "2103-07-24" }, { "title": "HISTOLOGICAL CHARACTERIZATION OF PNEUMOCYTES TYPE I AND PNEUMOCYTE TYPE II: A SUBJECT REVIEW", "url": "https://doi.org/10.23975/bjvetr.2031.175855", "sourceName": "Crossref", "evidenceLabel": "DOI-indexed publication", "publishedAt": "2031-08-01" }, { "title": "Expériences et recommandations à l’intégration du diabète de type 1 par les acteurs du système de santé au Cameroun – Une étude qualitative", "url": "https://doi.org/10.3917/spub.pr2.0051", "sourceName": "Crossref", "evidenceLabel": "DOI-indexed publication", "publishedAt": "2030-01-01" }, { "title": "Association of Two Genetic Variants (rs3765467 and rs1050450) Polymorphisms with Type 2 Diabetes Mellitus in Iraqi Patients Undergoing Hemodialysis", "url": "https://doi.org/10.21608/ejmm.2026.490039.2433", "sourceName": "Crossref", "evidenceLabel": "DOI-indexed publication", "publishedAt": "2027-07-01" }, { "title": "A Multimodal Discourse Analysis of Interpersonal Meaning in New-Type Farmers' Agricultural Promotion Short Videos on Douyin", "url": "https://doi.org/10.22158/eltls.v8n3p21", "sourceName": "Crossref", "evidenceLabel": "DOI-indexed publication", "publishedAt": "2027-05-07" }, { "title": "Human and mouse regenerative macrophages enhance beta cell survival, function, and proliferation.", "url": "https://pubmed.ncbi.nlm.nih.gov/42070103/", "sourceName": "PubMed", "evidenceLabel": "PubMed indexed literature", "publishedAt": "2026-12-31" }, { "title": "Is the intraportal or renal subcapsular space a preferable site for islet allo- and xeno-transplantation? A brief historical review.", "url": "https://pubmed.ncbi.nlm.nih.gov/42017902/", "sourceName": "PubMed", "evidenceLabel": "PubMed indexed literature", "publishedAt": "2026-12-31" }, { "title": "MLPH/RAB3A accelerates the differentiation of pancreatic stem cells to islet β-cells to control blood glucose in diabetic rats.", "url": "https://pubmed.ncbi.nlm.nih.gov/41774510/", "sourceName": "PubMed", "evidenceLabel": "PubMed indexed literature", "publishedAt": "2026-12-31" }, { "title": "Role of small intronic RNAs in the crosstalk between immune cells and β-cells during type 1 diabetes development.", "url": "https://pubmed.ncbi.nlm.nih.gov/41823267/", "sourceName": "PubMed", "evidenceLabel": "PubMed indexed literature", "publishedAt": "2026-12-01" } ], "sections": [ { "heading": "The evidence posture", "paragraphs": [ "Research records are not all equal. A PubMed or DOI record may represent a clinical study, review, device paper, mechanistic finding, animal study, or early-stage idea. The job of this page is to surface the source and keep the evidence label visible.", "The highest-value Type 1 diabetes watch topics include beta-cell replacement, islet biology, immune modulation, automated insulin delivery, CGM performance, hypoglycemia, pediatric care, and quality-of-life outcomes." ] }, { "heading": "Recent research records", "bullets": [ { "text": "Comparing of the Effects of Acceptance and Commitment Therapy and Emotion Regulation Training on Diabetes Empowerment — Journal of Client-Centered Nursing Care. Type: journal-article. Background: Diabetes mellitus is a widely diffused chronic condition that affects several aspects of patients’ lives. The patient’s life in this condition...", "sourceUrl": "https://doi.org/10.32598/jccnc.7.1.356.1" }, { "text": "Geographical distribution of Corydoras micracanthus Regan 1912 (Siluriformes: Callichthyidae), with comments on its behavior and type locality. — Revista del Museo Argentino de Ciencias Naturales. Type: journal-article", "sourceUrl": "https://doi.org/10.22179/revmacn.20.482" }, { "text": "Re-Evaluating the Efficacy of the Aqueous Leaf Extract of Bridelia ferrugenia and its Potential Combination with Metformin in the Management of Diabetes Mellitus — Journal of Medicinal Herbs and Ethnomedicine. Type: journal-article", "sourceUrl": "https://doi.org/10.5455/jmhe.2015.08.015" }, { "text": "A Birkhoff type transitivity theorem for non-separable completely metrizable spaces with applications to linear dynamics — Journal of Operator Theory. Type: journal-article", "sourceUrl": "https://doi.org/10.7900/jot.2011may12.1971" }, { "text": "HISTOLOGICAL CHARACTERIZATION OF PNEUMOCYTES TYPE I AND PNEUMOCYTE TYPE II: A SUBJECT REVIEW — Basrah Journal of Veterinary Research. Type: journal-article", "sourceUrl": "https://doi.org/10.23975/bjvetr.2031.175855" }, { "text": "Expériences et recommandations à l’intégration du diabète de type 1 par les acteurs du système de santé au Cameroun – Une étude qualitative — Santé Publique. Type: journal-article. Introduction : L’intégration de la prise en charge du diabète de type 1 (DT1) au Cameroun est un défi. En dépit de certaines initiatives de fourniture d’insuline gratuite aux enfan...", "sourceUrl": "https://doi.org/10.3917/spub.pr2.0051" }, { "text": "Association of Two Genetic Variants (rs3765467 and rs1050450) Polymorphisms with Type 2 Diabetes Mellitus in Iraqi Patients Undergoing Hemodialysis — Egyptian Journal of Medical Microbiology. Type: journal-article", "sourceUrl": "https://doi.org/10.21608/ejmm.2026.490039.2433" }, { "text": "A Multimodal Discourse Analysis of Interpersonal Meaning in New-Type Farmers' Agricultural Promotion Short Videos on Douyin — English Language Teaching and Linguistics Studies. Type: journal-article. This study selects 15 short videos published over the past year by new-type farmers (xin nong ren) on Douyin as research corpus. It adopts system...", "sourceUrl": "https://doi.org/10.22158/eltls.v8n3p21" }, { "text": "Human and mouse regenerative macrophages enhance beta cell survival, function, and proliferation. — Islets. Authors: Monajemi M, Craciun AS, Huang Q. Journal Article", "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/42070103/" } ] }, { "heading": "What needs editorial review", "bullets": [ { "text": "Whether the record is human clinical evidence, preclinical work, review material, device performance data, or commentary." }, { "text": "Whether outcomes matter to families: A1C, time in range, severe hypoglycemia, DKA, sleep, school, sports, treatment burden, and durability." }, { "text": "Whether a company, sponsor, or press release is driving the claim before independent evidence exists." } ] } ], "medicalDisclaimer": "This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.", "seo": { "title": "Type 1 diabetes research watch: recent papers and DOI records worth sorting", "description": "A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes." } }, { "id": "blog:2026-06-13:how-type1cure-labels-evidence", "slug": "2026-06-13-how-type1cure-labels-evidence", "title": "How Type1Cure labels Type 1 diabetes evidence before it becomes a headline", "dek": "The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.", "category": "Editorial Policy", "topic": "trust", "author": "Type1Cure Editorial Desk", "publishedAt": "2026-06-13T08:00:00.000Z", "updatedAt": "2026-06-13T09:17:02.630Z", "readingTimeMinutes": 3, "image": { "src": "/images/open-source/diabetes-awareness-air-force.jpg", "alt": "Diabetes awareness public health display.", "credit": "U.S. Air Force / Wikimedia Commons", "license": "Public domain", "sourceUrl": "https://commons.wikimedia.org/wiki/File:Diabetes_Awareness_(5907023).jpg" }, "tags": [ "editorial policy", "evidence labels", "trust", "medical guardrails" ], "sourceItemIds": [ "clinicaltrials:NCT07039942", "clinicaltrials:NCT06878872", "openfda-device-recall:219288", "openfda-device-recall:219289", "openfda-device-recall:219290", "clinicaltrials:NCT04963777" ], "sources": [ { "title": "French Prospective Multicentric Study in Real World", "url": "https://clinicaltrials.gov/study/NCT07039942", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-29" }, { "title": "Type 1 Diabetes Adolescents for Healthier Lifestyles Study", "url": "https://clinicaltrials.gov/study/NCT06878872", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-13" }, { "title": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: Versions 2.9.0 through 2.11.2 Produc...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219288", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: Versions 2.9.0 through 2.11.2 Pr...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219289", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "Dexcom, Inc.: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.5.0 and 1.6.0 Product...", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219290", "sourceName": "openFDA device recalls", "evidenceLabel": "FDA recall database", "publishedAt": "2026-05-11" }, { "title": "Prebiotics in Patients With Type 1 Diabetes", "url": "https://clinicaltrials.gov/study/NCT04963777", "sourceName": "ClinicalTrials.gov", "evidenceLabel": "Official recruiting registry", "publishedAt": "2026-05-01" } ], "sections": [ { "heading": "Why labels matter", "paragraphs": [ "Families looking for Type 1 diabetes breakthroughs are exposed to a constant mix of legitimate science, company promotion, device updates, creator experience, and cure hype. Type1Cure needs to make the source class visible before the headline is allowed to carry emotional weight.", "The site starts by keeping regulator, registry, peer-reviewed, nonprofit, company, media, and community sources in separate lanes. That prevents a viral post from being displayed as if it has the same clinical weight as an official trial record or FDA notice." ] }, { "heading": "The practical ranking", "bullets": [ { "text": "T0: official registries and regulators, including ClinicalTrials.gov and FDA databases." }, { "text": "T1: peer-reviewed or indexed research, including PubMed and DOI records." }, { "text": "T2-T3: nonprofit, institution, company, and press sources that may be useful but need context." }, { "text": "T4-T5: media, social, podcast, creator, and community signals that can be valuable but cannot be treated as medical proof." } ] }, { "heading": "The rule for families", "paragraphs": [ "A source can be useful without being actionable. Type1Cure’s job is to surface it, label it, link it, and explain what question it raises. Treatment decisions still belong with licensed clinicians and the family care team." ] } ], "medicalDisclaimer": "This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.", "seo": { "title": "How Type1Cure labels Type 1 diabetes evidence before it becomes a headline", "description": "The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language." } } ] }